CN113336758A - Novel synthesis method of compound 7-iodopyrrolo [2,1-f ] [1,2,4] triazin-4-amine - Google Patents

Novel synthesis method of compound 7-iodopyrrolo [2,1-f ] [1,2,4] triazin-4-amine Download PDF

Info

Publication number
CN113336758A
CN113336758A CN202010150266.XA CN202010150266A CN113336758A CN 113336758 A CN113336758 A CN 113336758A CN 202010150266 A CN202010150266 A CN 202010150266A CN 113336758 A CN113336758 A CN 113336758A
Authority
CN
China
Prior art keywords
compound
formula
iodopyrrolo
amine
triazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010150266.XA
Other languages
Chinese (zh)
Other versions
CN113336758B (en
Inventor
李耀强
刘志强
顾榕
陈剑
付翌秋
龚静
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Chempion Pharmaceutical Technology Co ltd
Original Assignee
Beijing Chempion Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Chempion Pharmaceutical Technology Co ltd filed Critical Beijing Chempion Pharmaceutical Technology Co ltd
Priority to CN202010150266.XA priority Critical patent/CN113336758B/en
Publication of CN113336758A publication Critical patent/CN113336758A/en
Application granted granted Critical
Publication of CN113336758B publication Critical patent/CN113336758B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

The invention provides a method for preparing a triazine compound shown as a formula (I). The invention takes pyruvic acid and formamidine as initial materials to synthesize an intermediate
Figure DSA0000203456430000011
The compound shown in the formula (I) can be obtained through two-step reaction. The method provided by the invention has mild conditions, is simple and convenient to operate, greatly reduces the cost, and is suitable for industrial mass production.

Description

Novel synthesis method of compound 7-iodopyrrolo [2,1-f ] [1,2,4] triazin-4-amine
Technical Field
The invention relates to a new synthesis and purification method of a compound 7-iodopyrrolo [2,1-f ] [1,2,4] triazine-4-amine, belonging to the fields of chemistry and medicine.
Background
7-iodopyrrolo [2,1-f ] [1,2,4] triazin-4-amine (CAS number: 1770840-43-1) is an important intermediate, the structure of which is a key starting material for Reidesciclovir and has the formula:
Figure BSA0000203456450000011
redysivir was used initially for the treatment of ebola virus disease and marburg virus infection and was later found to exhibit reasonable antiviral activity against more distantly related viruses such as respiratory syncytial virus, hunin virus, lassa fever virus and MERS. Therefore, the synthesis of the precursor fragment 7-iodopyrrolo [2,1-f ] [1,2,4] triazin-4-amine is key for further reducing the cost and improving the productivity.
At present, the synthesis method of 7-iodopyrrolo [2,1-f ] [1,2,4] triazine-4-amine is mainly a small-amount synthetic route reported by a patent (WO2007064931), which takes compound 01 and Boc hydrazine as starting materials, closes a ring to obtain an intermediate 02, further uses sulfonyl chloride isocyanate to obtain a compound 03 on a cyano group on a pyrrole 2 position, further removes a Boc protecting group under an acidic condition to obtain a compound 04, and then closes the ring with methyl ether and uses NIS to obtain a product compound 06 (7-iodopyrrolo [2,1-f ] [1,2,4] triazine-4-amine). The detailed reaction route is shown as the following formula.
Figure BSA0000203456450000012
As can be seen from the above routes, the ring closing step 1 has a yield of less than 60%, and chlorosulfonic acid isocyanate used in step 2 has high toxicity and needs column chromatography purification, so the routes are not suitable for industrial scale-up. From the viewpoint of cost, due to the compound 01 and BocN2H4The cost is large and the yield of step 1 is low, resulting in high overall route cost. Furthermore, we have developed the compound 7-iodopyrrolo [2,1-f][1,2,4]The novel route for triazin-4-amines is represented by the formula:
Figure BSA0000203456450000021
we used pyruvic acid and formamidine hydrochloride as starting materials, and hydrazine hydrate in ethanol under reflux to obtain triazine fragment (compound 03), and then further with bromo diethyl acetal to obtain compound 04, completing the construction of main ring. Further conversion of the hydroxyl group to chlorine using phosphorus oxychloride gives the key intermediate compound 05. Subsequently, preferential ammonolysis using compound 05 as starting material affords compound 06 with further iodination to afford product 07 (scheme A). At the same time, starting from compound 05, it is also possible to obtain compound 08 by preferential iodination and subsequent ammonolysis to obtain compound 07 (scheme B).
The method has the advantages that the yield of each step is high, the intermediate is easy to recrystallize and purify, isomers can be avoided, the yield and the purification difficulty are improved, and the method is favorable for industrial production. In addition, the raw materials of the route are basic chemicals, so that the price is low and easy to obtain, and the production cost of the product 7-iodopyrrolo [2,1-f ] [1,2,4] triazine-4-amine is greatly reduced.
Disclosure of Invention
The invention aims to develop a novel method for preparing 7-iodopyrrolo- [2,1-f ] [1,2,4] triazin-4-amine, and the method can improve the yield and reduce the production cost, so that the method is suitable for industrial mass production.
The invention provides a novel method for preparing 7-iodopyrrolo [2,1-f ] [1,2,4] triazine-4-amine. The method comprises the following steps:
1) the intermediate shown in (II) is formed by the ring closure of pyruvic acid and formamidine under the participation of hydrazine:
Figure BSA0000203456450000022
2) reacting the intermediate obtained in the step 1) as shown in the formula (II) with halogenated acetaldehyde or halogenated acetal to obtain an intermediate as shown in the formula (III):
Figure BSA0000203456450000023
3) carrying out dehydroxylation and chlorination on the intermediate obtained in the step 2) as shown in the formula (III) to obtain an intermediate as shown in the formula (IV):
Figure BSA0000203456450000031
4) converting the intermediate obtained in the step 3) as shown in the formula (IV) to obtain a target compound as shown in the formula (I):
Figure BSA0000203456450000032
in the step 1), formamidine hydrochloride or formamidine acetate can be used.
The solubility of hydrazine hydrate used in the step 1) may be 40% to 80%, or a salt of hydrazine such as hydrazine acetate, hydrazine hydrochloride, hydrazine sulfate, or the like may be used.
In the step 1), an alcohol solvent such as ethanol, isopropanol or tert-butanol is preferably used.
The reaction temperature of the step 1) is-20 ℃ to 100 ℃.
The step 2) uses halogenated acetaldehyde or halogenated acetal.
Further, chloroacetaldehyde or bromoacetaldehyde is preferably selected.
If halogenated acetal is used in the step 2), a catalytic amount of acid is added into the reaction system.
Further, the acid may be selected from hydrochloric acid, sulfuric acid, acetic acid, benzenesulfonic acid, p-toluenesulfonic acid, trifluoroacetic acid, or the like.
Further, the amount of the acid is 1 to 50% by mass of the halogenated acetal.
The dehydroxychlorination reagent used in the step 3) is phosphorus oxychloride or thionyl chloride.
Further, phosphorus oxychloride is preferably used.
In the step 4), the compound (IV) can be iodo to obtain a compound (I):
Figure BSA0000203456450000033
or the compound (IV) is iodo firstly and then is ammonolyzed to obtain the compound (I):
Figure BSA0000203456450000041
further, the iodinating agent may be selected from iodine, N-iodosuccinimide, or iodine chloride.
Further, the amination reaction may use aqueous ammonia or an alcoholic solution of ammonia, preferably an alcoholic solution of ammonia.
The invention provides a method for preparing triazine compounds. The preparation method is simple and convenient, has low cost and is suitable for industrial production. Obviously, many modifications, substitutions, and alterations are possible in light of the above teachings of the invention, without departing from the basic technical ideas of the invention, as defined by the following general technical knowledge and conventional practices of the art.
The present invention will be described in further detail with reference to the following examples. This should not be understood as limiting the scope of the above-described subject matter of the present invention to the following examples. All the technologies realized based on the above contents of the present invention belong to the scope of the present invention.
Detailed Description
The starting materials and equipment used in the embodiment of the present invention are known products and are obtained by purchasing commercially available products.
Example 1: synthesis of compound 6-methyl-1, 2, 4-triazin-5 (4H) -one.
Figure BSA0000203456450000042
Adding an ethanol solution of formamidine hydrochloride (compound 02) and hydrazine hydrate into a reaction bottle, cooling the system to-10 ℃, then adding the compound 01 into the reaction system, and adding a trace amount of acetic acid for catalysis. And heating and refluxing the system for 5 hours, cooling and filtering after the reaction is finished, and concentrating the filtrate to be dry to obtain a crude product of the compound 03, wherein the crude product is directly used for the next reaction without purification.
Example 2: synthesis of the compound pyrrolo [2,1-f ] [1,2,4] triazin-4 (3H) -one.
Figure BSA0000203456450000043
Adding the crude product of the compound 03 into water, then adding 2-bromo-diglycal into the system, adding trace hydrochloric acid into the system, then heating to 90 ℃ for reaction for 3 hours, cooling the system to room temperature after the raw materials disappear, filtering, and washing a filter cake with cold water to obtain the compound 04 (the yield of the two steps is 65%).
Example 3: synthesis of 4-chloropyrrolo [2,1-f ] [1,2,4] triazine.
Figure BSA0000203456450000051
DIPEA and phosphorus oxychloride are added into a toluene solution of a compound 04, a system is heated to 120 ℃ to react for 24 hours, after raw materials disappear, the reaction liquid is added into ice water to be quenched, then sodium bicarbonate is added to adjust the pH value to be neutral, the system is subjected to liquid separation, an aqueous phase is extracted for 2 times by toluene, organic phases are combined, dried, filtered and concentrated to obtain the compound 05 (the yield is 93%).
Example 4: synthesis of compound 4-aminopyrrolo [2,1-f ] [1,2,4] triazine
Figure BSA0000203456450000052
Compound 05 was dissolved in tetrahydrofuran, and then, an amine methanol solution was added to the system, the system was stirred at room temperature for 0.5 hour, then, at 50 ℃ overnight, after TLC showed disappearance of the starting material, water was added to quench the reaction, the mixture was stirred at room temperature for 2 hours, and filtered, and the cake was collected to give compound 06 (yield: 82%).
Example 5: synthesis of compound 7-iodopyrrolo [2,1-f ] [1,2,4] triazin-4-amine
Figure BSA0000203456450000053
Dissolving the compound 06 in dimethyl sulfoxide, adding NIS in batches, stirring the system at room temperature for 16 hours, adding water into the system to quench the reaction after TLC identification of the disappearance of the raw materials, continuing stirring for 2 hours, filtering the system, and collecting a filter cake to obtain a compound 07 (yield: 75%)
Example 6: synthesis of compound 4-chloro-7-iodopyrrolo [2,1-f ] [1,2,4] triazine
Figure BSA0000203456450000054
Dissolving Compound 05 in anhydrous dichloromethane, adding NIS, stirring at room temperature for 16 hr, TLC monitoring for disappearance of raw material, filtering, collecting filtrate, washing filtrate with sodium sulfite aqueous solution twice, collecting organic phase, drying organic phase, filtering, collecting filtrate, and concentrating to obtain Compound 06 (yield: 75%)
Example 7: synthesis of compound 7-iodopyrrolo [2,1-f ] [1,2,4] triazin-4-amine
Figure BSA0000203456450000061
Dissolving the compound 05 in tetrahydrofuran, adding an amine methanol solution, stirring the reaction at room temperature for 2 hours after the addition is finished, heating to 55 ℃ for reaction for 16 hours, adding water to quench the reaction after TLC (thin layer chromatography) monitors that raw materials disappear, removing an organic phase by concentrating the mixture under reduced pressure, adding ethanol into the system, pulping for 2 hours, filtering, and collecting a filter cake to obtain the compound 07 (yield: 81%).

Claims (5)

1. A preparation method of triazine compounds shown in formula (I),
Figure FSA0000203456440000011
the method is characterized by comprising the following steps:
1) the intermediate shown in (II) is formed by the ring closure of pyruvic acid and formamidine under the participation of hydrazine:
Figure FSA0000203456440000012
2) reacting the intermediate obtained in the step 1) as shown in the formula (II) with halogenated acetaldehyde or halogenated acetal to obtain an intermediate as shown in the formula (III):
Figure FSA0000203456440000013
3) carrying out dehydroxylation and chlorination on the intermediate obtained in the step 2) as shown in the formula (III) to obtain an intermediate as shown in the formula (IV):
Figure FSA0000203456440000014
4) converting the intermediate obtained in the step 3) as shown in the formula (IV) to obtain a target compound as shown in the formula (I):
Figure FSA0000203456440000015
2. the method of claim 1, wherein pyruvic acid is condensed with formamidine and hydrazine to form compound (II) in step 1).
3. The method as claimed in claim 1, wherein step 2) uses a halogenated acetaldehyde or a halogenated acetal.
4. The method as claimed in claim 1, wherein the dehydroxychlorination reagent used in step 3) is phosphorus oxychloride or thionyl chloride.
5. The method of claim 1, wherein in step 4), compound (IV) is converted to an amino intermediate and iodo to give compound (I):
Figure FSA0000203456440000021
or the compound (IV) is iodo firstly and then is ammonolyzed to obtain the compound (I):
Figure FSA0000203456440000022
CN202010150266.XA 2020-03-03 2020-03-03 Novel synthesis method of compound 7-iodopyrrolo [2, 1-f ] [1, 2, 4] triazin-4-amine Active CN113336758B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010150266.XA CN113336758B (en) 2020-03-03 2020-03-03 Novel synthesis method of compound 7-iodopyrrolo [2, 1-f ] [1, 2, 4] triazin-4-amine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010150266.XA CN113336758B (en) 2020-03-03 2020-03-03 Novel synthesis method of compound 7-iodopyrrolo [2, 1-f ] [1, 2, 4] triazin-4-amine

Publications (2)

Publication Number Publication Date
CN113336758A true CN113336758A (en) 2021-09-03
CN113336758B CN113336758B (en) 2022-08-19

Family

ID=77467448

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010150266.XA Active CN113336758B (en) 2020-03-03 2020-03-03 Novel synthesis method of compound 7-iodopyrrolo [2, 1-f ] [1, 2, 4] triazin-4-amine

Country Status (1)

Country Link
CN (1) CN113336758B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017184668A1 (en) * 2016-04-20 2017-10-26 Gilead Sciences, Inc. Methods for treating flaviviridae virus infections
CN108348526A (en) * 2015-09-16 2018-07-31 吉利德科学公司 The method for treating Arenaviridae and coronaviridae virus infection
CN109348715A (en) * 2016-03-28 2019-02-15 因赛特公司 Pyrrolotriazine compounds as TAM inhibitor
CN110003215A (en) * 2013-11-11 2019-07-12 吉利德科学公司 It can be used for treating pyrrolo- [1,2-f] [1,2,4] triazine of respiratory syncytial virus infection

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110003215A (en) * 2013-11-11 2019-07-12 吉利德科学公司 It can be used for treating pyrrolo- [1,2-f] [1,2,4] triazine of respiratory syncytial virus infection
CN108348526A (en) * 2015-09-16 2018-07-31 吉利德科学公司 The method for treating Arenaviridae and coronaviridae virus infection
CN109348715A (en) * 2016-03-28 2019-02-15 因赛特公司 Pyrrolotriazine compounds as TAM inhibitor
WO2017184668A1 (en) * 2016-04-20 2017-10-26 Gilead Sciences, Inc. Methods for treating flaviviridae virus infections

Also Published As

Publication number Publication date
CN113336758B (en) 2022-08-19

Similar Documents

Publication Publication Date Title
JP6574474B2 (en) Process for producing chiral dipeptidyl peptidase-IV inhibitor
CN111187269A (en) Synthetic method of Reidesciclovir intermediate
CN111217819A (en) Synthetic method of sepiatinib
CN104761555A (en) Tofacitinib intermediate preparation method and method for preparing tofacitinib or its salt by using tofacitinib intermediate preparation method
CN113336758B (en) Novel synthesis method of compound 7-iodopyrrolo [2, 1-f ] [1, 2, 4] triazin-4-amine
CN108822112A (en) A kind of preparation method of tropsch imatinib compound
CN111116587A (en) Preparation method of avibactam intermediate compound
CN101018764A (en) Process for synthesis of 4-4'-diamino-diphenyl-sulfone
CN113336761B (en) Preparation method of JAK inhibitor key intermediate
CN105646374B (en) A kind of preparation method of erlotinib Hydrochloride
CN110016023B (en) Simple preparation method of palbociclib
ES2446365T3 (en) Neramexane preparation procedure
CN111100042B (en) Preparation method of 2-methoxy-5-sulfonamide benzoic acid
CN105175316B (en) A kind of method for preparing laxative picosulfate sodium
AU2011319706B2 (en) Process for the preparation of anagrelide and analogues thereof
CN115477653B (en) Preparation method of trehalfline key intermediate and trehalfline
CN114787163A (en) Process for preparing (9S) -2-bromo-9- (2,3, 4-trifluorophenyl) -6,7,8, 9-tetrahydro-5H- [1,2,4] triazolo [1,5-a ] azepine
Heyman Preparation of isatoates from isatoic anhydride
CN113072514A (en) Preparation method of cycleanine and intermediate thereof
CN111574540B (en) Preparation method of Degatinib
CN111560021B (en) Degaitinib intermediate and preparation method thereof
CN115043845B (en) Synthesis method of sildenafil
CN113773323B (en) Preparation method of 3R-amino substituted butyramide derivative
CN111646982B (en) Synthesis method of norketotifen
CN117677617A (en) Preparation method of hepatitis B virus nucleocapsid inhibitor

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Yu Tingting

Document name: Notice of publication and entry into substantive examination of patent application for invention

GR01 Patent grant
GR01 Patent grant